Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo. (Q55447773)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article
Language Label Description Also known as
English
Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo.
scientific article

    Statements

    title
    Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo (English)
    1 reference
    stated in
    Europe PubMed Central
    PMC publication ID
    6033369
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29983871%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    5 April 2020
    author name string
    cites work

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q55447773&oldid=2165270120"